×

Drug device configured for wireless communication

  • US 10,137,288 B2
  • Filed: 11/27/2017
  • Issued: 11/27/2018
  • Est. Priority Date: 06/03/2014
  • Status: Active Grant
First Claim
Patent Images

1. An ingestible drug delivery device, formed by a device manufacturer, and configured for wireless communication, said drug delivery device comprising:

  • a capsule body comprising;

    a sensor for sensing at least one biologic condition within a patient;

    a bioactive substance module comprising a container for holding a volume and/or quantity of bioactive substance therein and a microactuator for dispensing said bioactive substance from said container to a location outside of said capsule body;

    an electronics module, coupled to said sensor and said bioactive substance module, said electronics module comprising a processor, a transponder and a memory, said memory configured for storing data related to a unique device ID and to a patient identification and configured for storing respective flags set by the device manufacturer and a pharmacist;

    a power source coupled to said sensor, said bioactive substance module and said electronics module; and

    wherein said processor activates said microactuator to dispense said bioactive substance only if said processor verifies the following conditions;

    (a) a first flag is set by the device manufacturer;

    (b) a second flag is set by the pharmacist; and

    (c) a match exists between said patient identification stored in said memory and a patient identification transmitted from an external patient interface device that communicates with said ingested drug device; and

    wherein said processor does not activate said microactuator to dispense said bioactive substance if any one of said conditions (a) (c) is not verified.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×